Beverly Hills, MI, United States of America

Jeffrey C Johnson


 

Average Co-Inventor Count = 2.3

ph-index = 6

Forward Citations = 130(Granted Patents)


Location History:

  • Birmingham, MI (US) (1987 - 1990)
  • Beverly Hills, MI (US) (1998 - 2007)
  • Flemington, NJ (US) (2017 - 2019)

Company Filing History:


Years Active: 1987-2019

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovative Mind of Jeffrey C. Johnson: Pioneering Cell Line Technologies

Introduction: Jeffrey C. Johnson, an accomplished inventor based in Flemington, NJ, has made significant strides in the field of biotechnology. With two patents to his name, Johnson's work focuses on the development of advanced cell line technologies, which represent crucial advancements in the creation of proteins with non-natural amino acids.

Latest Patents: Johnson's latest patents showcase his groundbreaking approach to stabilizing eukaryotic cell lines. These inventions provide a process for integrating a gene encoding a target protein containing one or more non-natural amino acids, which are encoded by a nonsense codon. The process involves culturing the cell line under specific conditions that mitigate the adverse effects of tRNA expression on cell viability and growth. This innovation not only enhances the functionality of the cell lines but also opens up new possibilities in protein engineering.

Career Highlights: Jeffrey C. Johnson is currently associated with Medimmune Limited, where he continues to work on pioneering projects within the biopharmaceutical sector. His expertise in molecular biology and biotechnology has positioned him as a leading figure in the innovation of cell line stabilization techniques.

Collaborations: Throughout his career, Johnson has collaborated with several notable professionals, including Kenneth H. Grabstein and Michael Van Brunt. These partnerships have facilitated the exchange of ideas and knowledge, driving forward the research and development of innovative biotechnological solutions.

Conclusion: Jeffrey C. Johnson’s contributions to the field of biotechnology, particularly through his patented technologies, exemplify the impact of innovation in science and medicine. His work at Medimmune Limited continues to push the boundaries of what is possible, paving the way for future advancements in protein engineering and biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…